These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31568022)

  • 21. Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.
    Mellington FE; Dayan CM; Dickinson AJ; Hickey JL; MacEwen CJ; McLaren J; Perros P; Rose GE; Uddin J; Vaidya B; Foley P; Lazarus JH; Mitchell A; Ezra DG;
    Orbit; 2017 Jun; 36(3):159-169. PubMed ID: 28296512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence, Risk Factors, and Clinical and Biochemical Characteristics of Alemtuzumab-Induced Graves Disease.
    Ueland GÅ; Ueland HO; Stokland AM; Bhan A; Schønberg A; Sollid ST; Morgas DE; Holmøy T; Lima K; Methlie P; Løvås K; Torkildsen Ø; Husebye ES
    J Clin Endocrinol Metab; 2024 Jan; 109(2):344-350. PubMed ID: 37708353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy.
    Yu SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Thyroid; 2017 Sep; 27(9):1185-1193. PubMed ID: 28805160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration of the Intestinal Microbial Flora and the Serum IL-17 Level in Patients with Graves' Disease Complicated with Vitamin D Deficiency.
    Yang M; Li F; Zhang R; Wu Y; Yang Q; Wang F; Yu Z; Liu J; Cha B; Gong Q; Yang B; Sun B; Ding H
    Int Arch Allergy Immunol; 2022; 183(2):225-234. PubMed ID: 34544076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral versus unilateral thyroid eye disease.
    Kashkouli MB; Kaghazkanani R; Heidari I; Ketabi N; Jam S; Azarnia S; Pakdel F
    Indian J Ophthalmol; 2011; 59(5):363-6. PubMed ID: 21836341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy.
    Roos JCP; Paulpandian V; Murthy R
    Eye (Lond); 2019 Feb; 33(2):212-217. PubMed ID: 30401900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [LIFESTYLE ADJUSTMENT AS THERAPEUTIC TOOL IN THYROID EYE DISEASE].
    Vashdi I; Gur Z
    Harefuah; 2022 Apr; 161(4):223-227. PubMed ID: 35466606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy.
    Ueland HO; Ulvik A; Løvås K; Wolff ASB; Breivik LE; Stokland AM; Rødahl E; Nilsen RM; Husebye E; Ueland GÅ
    J Clin Endocrinol Metab; 2023 May; 108(6):1290-1297. PubMed ID: 36611247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reactivation of Graves' Disease and Thyroid Eye Disease following COVID-19 Vaccination - A Case Report.
    Hung CW; Hung CH
    Ocul Immunol Inflamm; 2023 Aug; 31(6):1286-1290. PubMed ID: 36796028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypo vs. hyperthyroid eye disease: is there any difference?
    Eshraghi B; Pourazizi M; Abbasi M; Mohammadbeigy I
    BMC Ophthalmol; 2023 Feb; 23(1):58. PubMed ID: 36765316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of risk of obstructive sleep apnea with thyroid eye disease and its activity.
    Kumari N; Arora N; Das S; Tiple S; Singh H; Patidar N; Mishra M; Majumdar A
    Indian J Ophthalmol; 2023 Dec; 71(12):3711-3714. PubMed ID: 37991309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].
    Wall JR; Lahooti H
    Endokrynol Pol; 2011; 62 Suppl 1():1-7. PubMed ID: 22125104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Risk of Obstructive Sleep Apnea With Thyroid Eye Disease: Compressive Optic Neuropathy.
    Habib LA; Godfrey KJ; Mathews P; De Rojas J; Kazim M
    Ophthalmic Plast Reconstr Surg; 2019; 35(3):232-234. PubMed ID: 30134386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severity of thyroid eye disease and type-2 diabetes mellitus: Is there a correlation?
    Ramamurthy LB; Rangarajan V; Srirao N; Malini B; Bansal R; Yuvarajan K
    Indian J Ophthalmol; 2020 Jun; 68(6):1127-1131. PubMed ID: 32461446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sight-Threatening Thyroid Eye Disease: Role of Diabetes Mellitus and Interaction with Other Risk Factors.
    Rath S; Pattnaik M; Tripathy D; Mohapatra S; Panigrahy B; Ali MH
    Ophthalmic Plast Reconstr Surg; 2021 Jul-Aug 01; 37(4):352-360. PubMed ID: 33060509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid eye disease.
    Cockerham KP; Chan SS
    Neurol Clin; 2010 Aug; 28(3):729-55. PubMed ID: 20637998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic indicators for the development of strabismus among patients with graves' ophthalmopathy.
    Lin TY; Li N; Yeh MW; Leung AM; Rootman DB
    J Clin Transl Endocrinol; 2017 Sep; 9():38-40. PubMed ID: 29067268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How patients experience thyroid eye disease.
    Smith TJ; Hegedüs L; Lesser I; Perros P; Dorris K; Kinrade M; Troy-Ott P; Wuerth L; Nori M
    Front Endocrinol (Lausanne); 2023; 14():1283374. PubMed ID: 38027128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Other Autoimmune Diseases With Thyroid Eye Disease.
    Kelada M; Avari P; Farag S; Akishar R; Jain R; Aziz A; Feeney C; Bravis V; Meeran K; Lee V
    Front Endocrinol (Lausanne); 2021; 12():644200. PubMed ID: 33746907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cigarette smoking and thyroid eye disease: a systematic review.
    Thornton J; Kelly SP; Harrison RA; Edwards R
    Eye (Lond); 2007 Sep; 21(9):1135-45. PubMed ID: 16980921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.